L408 (Darifenacin Hydrobromide Extended-Release 7.5 mg)

Pill with imprint L408 is White, Round and has been identified as Darifenacin Hydrobromide Extended-Release 7.5 mg. It is supplied by Alembic Pharmaceuticals Inc.

Darifenacin is used in the treatment of overactive bladder; urinary frequency; urinary incontinence and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Darifenacin 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for L408

Darifenacin Hydrobromide Extended-Release

Imprint: L408
Strength: 7.5 mg
Color: White
Size: 8.00 mm
Shape: Round
Availability: Prescription only
Drug Class: Urinary antispasmodics
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: Alembic Pharmaceuticals Inc.
Manufacturer: Alembic Pharmaceutical Limited
National Drug Code (NDC): 62332-0223
Inactive Ingredients: hypromelloses, povidone k30, calcium phosphate dibasic anhydrous, magnesium stearate, titanium dioxide, polyethylene glycol 1500, magnesium silicate
Note: Inactive ingredients may vary.